Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway

Molecular and Cellular Biology

Volumn 27, Issue 8, 2007, Pages 3098-3108

  Wang, XiaoZhe ^a   Kennedy, Richard D ^a   Ray, Kallol ^a   Stuckert, Patricia ^a   Ellenberger, Tom ^b   D'Andrea, Alan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BRCA2 PROTEIN; CHECKPOINT KINASE 1; DNA; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA PROTEIN; MITOMYCIN C; MUTANT PROTEIN; SERINE; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; COMPLEX FORMATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; UBIQUITINATION;

AMINO ACID SEQUENCE; BRCA1 PROTEIN; CELL CYCLE; CELL DEATH; CONSERVED SEQUENCE; DNA DAMAGE; DNA REPLICATION; DRUG RESISTANCE; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP E PROTEIN; HELA CELLS; HUMANS; MITOMYCIN; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; UBIQUITIN;

EID: 34047190253     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02357-06     Document Type: Article

References (32)

1. Andreassen, P. R., A. D. D'Andrea, and T. Taniguchi. 2004. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18:1958-1963.
2. Auerbach, A. D. 1993. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp. Hematol. 21:731-733.
3. de Winter, J. P., F. Leveille, C. G. van Berkel, M. A. Rooimans, L. van Der Weel, J. Steltenpool, I. Demuth, N. V. Morgan, N. Alon, L. Bosnoyan-Collins, J. Lightfoot, P. A. Leegwater, Q. Waisfisz, K. Komatsu, F. Arwert, J. C. Pronk, C. G. Mathew, M. Digweed, M. Buchwald, and H. Joenje. 2000. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67:1306-1308.
4. Dunn, J., M. Potter, A. Rees, and T. M. Runger. 2006. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. Cancer Res. 66:11140-11147.
5. Garcia-Higuera, I., T. Taniguchi, S. Ganesan, M. S. Meyn, C. Timmers, J. Hejna, M. Grompe, and A. D. D'Andrea. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249-262.
6. Ho, G., S. Margossian, T. Taniguchi, and A. D. D'Andrea. 2006. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26:7005-7015.
7. Houghtaling, S., C. Timmers, M. Noll, M. Finegold, S. Jones, M. S. Meyn, and M. Grompe. 2003. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17:2021-2035.
8. Jin, J., T. Shirogane, L. Xu, G. Nalepa, J. Qin, S. J. Elledge, and J. W. Harper. 2003. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17:3062-3074.
9. Jin, Y., M. S. Dai, S. Z. Lu, Y. Xu, Z. Luo, Y. Zhao, and H. Lu. 2006. 14-3-3γ Binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J. 25:1207-1218.
10. Joenje, H., and K. J. Patel. 2001. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2:446-457.
11. Kennedy, R. D., and A. D. D'Andrea. 2005. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev. 19:2925-2940.
12. Kohn, E. A., C. J. Yoo, and A. Eastman. 2003. The protein kinase C inhibitor Go6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints. Cancer Res. 63:31-35.
13. Lin, S. Y., K. Li, G. S. Stewart, and S. J. Elledge. 2004. Human claspin works with BRCA1 to both positively and negatively regulate cell proliferation. Proc. Natl. Acad. Sci. USA 101:6484-6489.
14. Machida, Y. J., Y. Machida, Y. Chen, A. M. Gurtan, G. M. Kupfer, A. D. D'Andrea, and A. Dutta. 2006. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23:589-596.
15. Mack, P. C., D. R. Gandara, A. H. Lau, P. N. Lara, Jr., M. J. Edelman, and P. H. Gumerlock. 2003. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma. Cancer Chemother. Pharmacol. 51:337-348.
16. Mailand, N., J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas. 2000. Rapid destruction of human Cdc25A in response to DNA damage. Science 288:1425-1429.
17. 2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17:37-48.
18. Matsushita, N., H. Kitao, M. Ishiai, N. Nagashiroa, S. Hirano, K. Okawa, T. Ohta, D. S. Yu, P. J. McHugh, I. D. Hickson, A. R. Venkitaraman, H. Kurumizaka, and M. Takata. 2005. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19:841-847.
19. Meetei, A. R., J. P. de Winter, A. L. Medhurst, M. Wallisch, Q. Waisfisz, H. J. van de Vrugt, A. B. Oostra, Z. Yan, C. Ling, C. E. Bishop, M. E. Hoatlin, H. Joenje, and W. Wang. 2003. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35:165-170.
20. Meetei, A. R., A. L. Medhurst, C. Ling, Y. Xue, T. R. Singh, P. Bier, J. Steltenpool, S. Stone, I. Dokal, C. G. Mathew, M. Hoatlin, H. Joenje, J. P. de Winter, and W. Wang. 2005. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37:958-963.
21. Mosedale, G., W. Niedzwiedz, A. Alpi, F. Perrina, J. B. Pereira-Leal, M. Johnson, F. Langevin, P. Pace, and K. J. Patel. 2005. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12:763-771.
22. Niedernhofer, L. J., A. S. Lalai, and J. H. Hoeijmakers. 2005. Fanconi anemia (cross)linked to DNA repair. Cell 123:1191-1198.
23. O'Neill, T., L. Giarratani, P. Chen, L. Iyer, C. H. Lee, M. Bobiak, F. Kanai, B. B. Zhou, J. H. Chung, and G. A. Rathbun. 2002. Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J. Biol. Chem. 277:16102-16115.
24. Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93:11400-11406.
25. Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S. J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497-1501.
26. Sorensen, C. S., L. T. Hansen, J. Dziegielewski, R. G. Syljuasen, C. Lundin, J. Bartek, and T. Helleday. 2005. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell Biol. 7:195-201.
27. Taniguchi, T., and A. D. D'Andrea. 2002. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 100:2457-2462.
28. Taniguchi, T., I. Garcia-Higuera, P. R. Andreassen, R. C. Gregory, M. Grompe, and A. D. D'Andrea. 2002. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414- 2420.
29. Wang, X., P. R. Andreassen, and A. D. D'Andrea. 2004. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24:5850-5862.
30. 2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21:3445-3450.
31. 2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:285-289.
32. Zhao, H., and H. Piwnica-Worms. 2001. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21:4129-4139.